| Tag | Content |
|---|
EnhancerAtlas ID | HS162-00718 |
Organism | Homo sapiens |
Tissue/cell | Plasma_cell_myeloma |
Coordinate | chr1:161499900-161501580 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161501184-161501202 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161501180-161501198 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161500746-161500756 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161501180-161501201 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 |
|
| | Number of super-enhancer constituents: 15 | ID | Coordinate | Tissue/cell |
| SE_04668 | chr1:161498891-161504488 | Brain_Anterior_Caudate | | SE_07207 | chr1:161498982-161504752 | Brain_Hippocampus_Middle_150 | | SE_09773 | chr1:161497742-161504419 | CD14 | | SE_12218 | chr1:161499699-161501650 | CD3 | | SE_12655 | chr1:161500190-161500727 | CD34_adult | | SE_12761 | chr1:161500307-161500650 | CD34_fetal | | SE_12761 | chr1:161501118-161501331 | CD34_fetal | | SE_13488 | chr1:161498207-161504412 | CD34_Primary_RO01536 | | SE_15045 | chr1:161497584-161504740 | CD4_Memory_Primary_7pool | | SE_16658 | chr1:161499691-161501924 | CD4_Naive_Primary_8pool | | SE_20033 | chr1:161499313-161501693 | CD56 | | SE_20739 | chr1:161496350-161504511 | CD8_Memory_7pool | | SE_22428 | chr1:161499172-161501885 | CD8_primiary | | SE_39937 | chr1:161499262-161501453 | K562 | | SE_53676 | chr1:161499218-161501513 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161500960 | 161501200 | | chr1 | 161500608 | 161500899 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161528 | chr1 | 161498591 | 161503308 |
|
Enhancer Sequence | GTTAATCTTA GTCTCAACTG CTCCCTGATT TCATAGACCA GACTCCAGCC TACAATACAG 60
GAAAAATAGA TATAGTTCTA TATGTGCAGA GAAGCACAAA TAATTTTCGT AAATGTAGAT 120
ACCTAGGATA AAAGGCAGTG TTGACCGATC GAAAAGTCTT TCTCTAAGAA TTCAAACATA 180
ATTGCTGGTT GGTTCAAATC AGGAGGAAAA GTAAGGACGG AAAACACATA TTGTCAGGAG 240
TGGGATTCGA ACCCACGCCT CCAGGGGAGA CTGCGACCTG AACGCAGCGC CTTAGACCGC 300
TCGGCCATCC TGACACATGT TTTACCATGC TTCCTAATTT CTCCTAATTT TATCATATAC 360
TGATGGTGCA CGCTATCAGG TCACATTAAT GTGTCTATTT ACTGTTTCAA ATAAAATTGT 420
AACTCTCTCT AGACCTTGTC GCAAAGCGGG AAAAATGAAA CAGGCTCCGA CAGCTCTTTC 480
CTCTTTCCTC ACTACCCAAA CTAATCCTTA AGGCTCCATT TTCCCTGGCG ACTCTTCGAG 540
CGCCCCTCTG CTTCTGTAGA GGGGTCGAGC CATGTCAAGG TAGACCCTGT GTCGGCCCGT 600
CTCCCTCGGA TCCTCCGCAC CAATCACTGT TGCTGAATCC GACACCCGGC GGATCCAGTG 660
CGGAGTCTCG AACAGCTGCG GAGCTGGGAG CTACGGGACA TGAAGAGAGC GGGGTGGAAG 720
AGAAGACGGC GGAGGAAAAT CCCCCGGCGA TGCTCAACTG CGGCTTTCTC TCTCGGCTGT 780
GAGCCGGCTC CGCCCTCCAG CTTCCAGAGC CGGTGGCTTC TGCGTTCACC GCCCCGCGCC 840
GTTTGCGGGG CGGGGCTGAT TCATAAGAAT CGGTTCTCAC CAATGGAGGG CTTAGCTTGT 900
TTAACCTCAG GATCATAAAC AAAAGACACT GCTAGAACGG TCGGGAAAGT CATACGCTTT 960
GCTTATCTTA TATATAGATA TCTAAAACTC CAAACCGGGT ACGCGTTGGT GGTATAGTGG 1020
TGAGCATAGC TGCCTTCCAA GCAGTTGACC CGGGTTCGAT TCCCGGCCAA CGCAAGGGTT 1080
TTTGTCTTTC CTTCTACGAA AAACCTTTCT CAGTCAGAAC CTATAACGCG CTGTGTATCC 1140
GTTTTACGCC TCAACGAAGT ATCCGTTTTA CGCTTCAACG AAACTGCAGC AATACCTCAC 1200
TTTCCGTACT CGCTTCCTGT CTTTCCCCTG GCCTCTTTCT AAACCCAGGC GTTTTTTGAA 1260
GGGATTAAAT TCTGATGGTT CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA 1320
GGAATCTTTG GGATCATTTC AATCCTGGGA TGAGTCTTAG CTTCAGAAAG GGGCTCTTGT 1380
GTCTTCACTT GCGAGGTTCA TTCGCTAGCC ACGCACTATT GAGCACGTGA ACTTGGCTAG 1440
TTTCTCTAAG AAACTGCATT TTCAAATTTA GTCTTAGTAA ATAAATCAAT TGAAATAAAA 1500
TTAATAAGTG AAAATTTTAA AATGGATACT TAATAACTCA ACCATTGGAG AAGGTTTCAG 1560
TGCATTTGAA ACAACGTGGC TATTGAATCT ACTTTTTCAA TTGTAAATTT TATGAAATCT 1620
AAATACGGAT TTTTTTCCGA AGAAAATTTC CTTTCCGAGT TGAAATGTGC CGTCTTTAAG 1680
|
